Skip to main content
Targeted Therapy Thwarts Tumor Progression : Sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Targeted Therapy Thwarts Tumor Progression : Sunitinib, a drug that binds to multiple enzymes, offers new hope for patients resistant to imatinib.
User login
Username
Password
Reset your password
Type
Lead
score